NuCana (NCNA) News Today $1.21 0.00 (0.00%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for WeekDecember 13, 2024 | msn.comNuCana Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 25, 2024 | globenewswire.comNuCana’s NUC-3373 Shows Promise in Cancer TreatmentNovember 13, 2024 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Move Higher in Monday TradingNovember 12, 2024 | msn.comNuCana announces initial data from Phase 1b/2 modular study of NUC-3373November 12, 2024 | markets.businessinsider.comNuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or DocetaxelNovember 11, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Rise FridayOctober 18, 2024 | msn.comTruist Financial Sticks to Their Buy Rating for Nucana (NCNA)October 16, 2024 | markets.businessinsider.comBaillie Gifford's Strategic Acquisition of NuCana PLC SharesOctober 4, 2024 | gurufocus.comEuropean Equities Traded in the US as American Depositary Receipts Flat in Friday TradingSeptember 27, 2024 | msn.comNuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United StatesSeptember 25, 2024 | markets.businessinsider.comNuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United StatesSeptember 25, 2024 | globenewswire.comNUCANA SP.ADR 25/ LS-,04 (N04.MU)September 17, 2024 | uk.finance.yahoo.comNuCana plc (N04.F)September 17, 2024 | uk.finance.yahoo.comNuCana PLC ADRSeptember 17, 2024 | wsj.comNuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock SurgesSeptember 16, 2024 | finance.yahoo.comOppenheimer Sticks to Their Buy Rating for Nucana (NCNA)September 16, 2024 | markets.businessinsider.comNuCana ADRs Nearly Double on Positive Data From Metastatic Melanoma TreatmentSeptember 16, 2024 | marketwatch.comNuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024September 14, 2024 | globenewswire.comWilliam Blair Downgrades NuCana plc - Depositary Receipt () (NCNA)August 31, 2024 | msn.comNuCana plc: NuCana Announces Update for Phase 2 Randomized Colorectal Cancer StudyAugust 30, 2024 | finanznachrichten.deNuCana plunges despite trial setback for cancer drugAugust 30, 2024 | msn.comNuCana Shares Plunge 60% After Colorectal-Cancer Study DiscontinuedAugust 30, 2024 | marketwatch.comNuCana Stock Plunges On Colorectal Combo Therapy Trial Setback, Ends Mid-Stage Study After Disappointing DataAugust 30, 2024 | msn.comNuCana plunges after trial setback for cancer drugAugust 30, 2024 | seekingalpha.comNuCana Announces Update for Phase 2 Randomized Colorectal Cancer StudyAugust 29, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday TradingAugust 26, 2024 | msn.comWe're A Little Worried About NuCana's (NASDAQ:NCNA) Cash Burn RateAugust 21, 2024 | finance.yahoo.comNCNA Stock Earnings: NuCana Beats EPS for Q2 2024August 15, 2024 | markets.businessinsider.comNuCana plc: NuCana Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 15, 2024 | finanznachrichten.deNuCana Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 15, 2024 | globenewswire.comNuCana to Present at the Jefferies Global Healthcare ConferenceMay 30, 2024 | globenewswire.comNuCana to Present at TD Cowen’s 5th Annual Oncology Innovation SummitMay 21, 2024 | finance.yahoo.comNuCana to Present at TD Cowen's 5th Annual Oncology Innovation SummitMay 21, 2024 | globenewswire.comNCNA Stock Earnings: NuCana Beats EPS for Q1 2024May 16, 2024 | msn.comNuCana plc: NuCana Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 16, 2024 | finanznachrichten.deNuCana Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 16, 2024 | globenewswire.comNuCana Regains Compliance with Nasdaq Minimum Bid Price RequirementMay 1, 2024 | globenewswire.comNuCana plc (NCNA)April 18, 2024 | finance.yahoo.comNuCana Announces Completion of ADS Ratio ChangeApril 16, 2024 | finance.yahoo.comTrading was temporarily halted for "NCNA" at 07:04 PM with a stated reason of "News pending."April 16, 2024 | marketbeat.comNuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical StudyApril 9, 2024 | globenewswire.comNuCana Stock (NASDAQ:NCNA), Quotes and News SummaryApril 5, 2024 | benzinga.comWhy NuCana (NCNA) Shares Are Trading LowerMarch 28, 2024 | msn.comNuCana plc: NuCana Announces Plan to Implement ADS Ratio ChangeMarch 27, 2024 | finanznachrichten.deNuCana American Depositary Shares Fall on News of Planned Ratio ChangeMarch 27, 2024 | marketwatch.comNuCana Announces Plan to Implement ADS Ratio ChangeMarch 27, 2024 | globenewswire.comNucana (NCNA) Receives a Hold from TD CowenMarch 25, 2024 | markets.businessinsider.comNuCana: Q4 Earnings InsightsMarch 20, 2024 | benzinga.comNuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business UpdateMarch 20, 2024 | globenewswire.com Get NuCana News Delivered to You Automatically Sign up to receive the latest news and ratings for NCNA and its competitors with MarketBeat's FREE daily newsletter. Email Address First JFK… next Elon? (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger. I share with you in this special investigative documentary. NCNA Media Mentions By Week NCNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NCNA News Sentiment▼0.000.59▲Average Medical News Sentiment NCNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NCNA Articles This Week▼01▲NCNA Articles Average Week Get NuCana News Delivered to You Automatically Sign up to receive the latest news and ratings for NCNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Marinus Pharmaceuticals News Today Aspira Women's Health News Today Sol-Gel Technologies News Today ImmunoPrecise Antibodies News Today Imunon News Today Kazia Therapeutics News Today CervoMed News Today Kiora Pharmaceuticals News Today Relmada Therapeutics News Today Talphera News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NCNA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana plc Please log in to your account or sign up in order to add this asset to your watchlist. Share NuCana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
